especially about drinking and driving, might have influenced this more impressionable age group. Another possible explanation might be the increase in the unemployment rate among young people between 1978 and 1985. Some of this newly formed section of the unemployed might be expected to drink less because they could not afford it.
Among women the picture was different. In 1985 women consumed on average more alcohol than in 1978 (5-1 units v 4-2 units). Although the percentage of non-drinkers rose significantly (51% v 42%), the average alcohol consumption per woman drinker was significantly higher in 1985 than in 1978 (10-4 units v 7-2 units). Thus women seem, to have "polarised" to some degree. More women were not drinking, but those who were drinking drank more. Apart from the current vogue for "healthy living," one factor influencing the increase in the numbers of non-drinkers may have been government sponsored negative advertising. This, however, was having no effect on those women who were drinking. For them the relative cheapness of alcohol in 1985 compared with 1978 could well have been a more relevant factor.67 Likewise, the pressure of positive advertising from the Brewers Society plus the liberation of women, such that their lifestyles (and therefore patterns of drinking) more closely resembled those of men, may also have contributed to this increase. ' Whatever the reason for this increase, it is important to reverse this trend. Women are more sensitive to alcohol damage,' and the inherent risk of increased consumption must therefore be made clear. Perhaps further advertising campaigns should highlight this risk.
The findings on regional variations must be considered with caution because ofthe small sample size. Nevertheless, rather broad agreement was seen between our survey and that of Wilson.' Both tended to show regional variation in consumption, with the northern areas, London, and Wales consuming the most, while East Anglia, the south west, and the south east consumed the least.
Like drinking. This underage group showed similar consumption patterns to the other age groups, except for those over 65. Given the relative immaturity of 16 and 17 years olds such adult consumption patterns are likely to produce an increased incidence of alcohol related problems.
Consumption per head of alcohol correlates well with certain markers of alcohol morbidity and mortality (drunkenness convictions, drinking and driving offences, first admissions to hospital for alcohol dependence, death from cirrhosis of the liver)." Therefore we hope the fact that overall alcohol intake did not change between 1978 and 1985 heralds an eventual downturn in consumption with a resulting reduction in alcohol related harm.
Such a pattern was in fact seen over the same seven years in several European countries. Per capita consumption in litres of absolute alcohol fell between 1978 and 1985 in France (16-3 to 13-9 litres), Germany (12-9 to 11'3 litres), Italy (12-0 to 9 4 litres), and Spain (14-3 to 11-8 litres). Consumption in these countries in 1978 was, however, considerably greater than in the UK (7-2 litres). For those European countries with a more equivalent 1978 consumption a different pattern was seen. Thus intake increased in Belgium (10-2 to 10-8 litres), Denmark (8'9 to 9-8 litres), and Portugal (9-9 to 13-1 litres), dramatically in the last case; the Netherlands showed a small decline (8-9 to 8-7 litres). When compared with other European countries, Britain's performance was middling.
Probably the single most important reason why alcohol intake remained stable between 1978 and 1985 was the relative cost of alcohol. Over the period the "work equivalent" ofa bottle ofwhisky changed from 2 hours 24 minutes to 2 hours 11 minutes and the percentage of disposable income spent on alcohol increased from 7 3 to 7 4%.' The relative cost of alcohol thus changed little, and this might well account for the observed stability in alcohol consumption. Nose and throat swabs were obtained from all the immediate family-father, mother, a 3 year old brother, a 2 year old sister-and the index patient. The resistant strain was grown from the nose swabs ofthe index patient and the 3 year old sibling. A sensitive pneumococcus was grown from the nose of the 2 year old, whereas no pneumococci were grown from the parents. The neonate's infected eye was treated for three weeks Acquired factor VIII inhibitor associated with lung abscess Haemoptysis in chronic bronchitis is common and may be worsened by any generalised bleeding disorder. We report on a patient who developed a lung abscess and was found to have a coagulopathy due to an acquired factor VIIIC inhibitor.
Case report
A 70 year old man with dhronic bronchitis was admitted with haemoptysis; he had not noted abnormal bleeding previously. On admission his sputum was bloodstained and he had signs of consolidation of the right middle lobe, which was confirmed by chest radiography. Despite antibiotic treatment cavitation developed in the consolidated lobe; a lung tumour wasexcluded at bronchoscopy. Extensive superficial bruising and petechias and prolonged bleeding from venepuncture sites were noted.
Platelet count and morphology were normal. Activated partial thromboplastin time was prolonged to 84 s (normal range 21-37 s) and bleeding time to >20 minutes (normal range 2-9 minutes). Prothrombin time, thrombin time, and concentrations of flbrinogen and fibrin degradation products were within the normal range. Von Willebrand factorwas 368% (normal range 60-160%), platelet aggregation and von Willebrand factor multimer pattern were normal. The prolonged activated partial prothrombin time was caused by a low factor VIIIC concentration (1%<) (normal range 60-160%). His plasma containedafactor VIIIC inhibitor at a concentration of 37 Bethesda units.' The inhibitor had no activity against porcine factor VIIIC. He was treated with continuous antibiotics for two months; the haemoptysis resolved in six weeks, his temperature returned to normal in eight weeks, and clearance of the abscess took 23 weeks.
One week after abnormal bleeding was first noted he had an episode of profuse haematuria that required treatment with cryoprecipitate. This increased his factor VIIIC concentration to 10%/o, which was one fifth of the maximum rise predicted in the absence of a factor VIIIC inhibitor. The Comment Acquired inhibitors to factor VIIIC in non-haemophiliacs are rare but may develop in association with autoimmune disorders, malignancy, and pregnancy. Nearly half of all patients have no detectable underlying disorder.2 In most cases the pattern ofspontaneous haemorrhage is similar to that in patients with inherited factor VIIIC deficiency (haemophilia A). 3 The decline in factor VIIIC inhibitor concentration in our patient as the lung abscess resolved suggested an association, although, interestingly, the inhibitor persisted at a lower concentration when he was well.
A prolonged bleeding time is not characteristic of factor VIIIC deficiency even if inhibitors are present: in this our patient's illness resembled von Willebrand's disease, although the antigen structure and activity of von Willebrand factor were normal. This is analagous to the bleeding disorder in renal failure, in which the bleeding time may be corrected with cryoprecipitate,4 although the plasma concentration of von Willebrand factor is usually already increased.5 The mechanism whereby cryoprecipitate corrects bleeding time in renal failure is not fully understood, although it may increase the ratio ofhigh to low molecular weight oligomers of von Willebrand factor. This mechanism may have operated in our patient, although as in renal failure the changes in the multimer pattern of von Willebrand factor were too-subtle to be picked up by sodium dodecylsulphate electrophoresis.
Although haemoptysis is well recognised in patients with lung abscesses, basic coagulation screening should be carried out to exclude a generalised bleeding disorder. Identification of an associated coagulopathy in patients with other medical problems may substantially alter management.
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